Delivery Order SPE2DE24D0021-SPE2D625F3EJW
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,953.78 by the Defense-oriented Medical Supply Chain federal agency for the procurement of vaginal positive control solutions (6x0.9mL per unit). The contract, awarded on August 20, 2025, with an ultimate completion date of August 27, 2025, utilizes fixed price pricing with economic price adjustment terms and carries no set-aside designation. Performance will take place in Pittsburgh, Pennsylvania. This delivery order...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $1,883.44 for vaginal positive control specimens (6 units × 0.9 milliliters each) by the Department of Defense's Medical Supply Chain division. This fixed-price contract with economic price adjustment authority is set for completion by September 17, 2025, and will be performed in Pittsburgh, Pennsylvania. As a child contract under a larger vehicle, this delivery order represents a routine procurement of specialized...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,953.78 by the Defense Medical Supply Chain on August 14, 2025, for the supply of vaginal positive control material in 6x0.9ml units. The contract, which employs fixed-price pricing with economic price adjustment terms, carries a completion date of August 21, 2025, and will be performed in Pittsburgh, Pennsylvania. This award represents a child contract under a larger vehicle and was made through open competition with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order on September 9, 2025, valued at $2,772.01 for the procurement of vaginal positive control solutions (6x0.9ml per unit) from the Defense Medical Supply Chain. This is a fixed price contract with economic price adjustment provisions, with a completion date of September 16, 2025. The contract was awarded without a set-aside designation through open competition, and will be fulfilled at Fisher Scientific's Pittsburgh, Pennsylvania...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $3,012.58 by the Department of Defense's Medical Supply Chain on August 12, 2025, for the provision of vaginal positive control reagent (6 units at 0.9 milliliters each). This fixed-price contract with economic price adjustment provisions is scheduled for completion by August 19, 2025, with performance taking place in Pittsburgh, Pennsylvania. The award utilized open competition without set-aside designations, reflecting...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,425.78 on August 13, 2025, for the procurement of vaginal negative control specimens (6 x 0.9 milliliter each). This fixed-price contract with economic price adjustment will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 20, 2025. The award was made without a set-aside designation, reflecting Fisher Scientific's competitive standing in open federal procurement. The funding agency is...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,605.04 on August 7, 2025, for the procurement of vaginal positive control reagents (6 units of 0.9 milliliters each) to support medical supply chain operations for the Department of Defense. The contract is fixed price with economic price adjustment provisions and carries an ultimate completion date of August 14, 2025. Performance will be executed in Pittsburgh, Pennsylvania. This delivery order represents a child...
- The U.S. government agency Defense Logistics Agency (DLA) awarded a fixed-price delivery order contract worth $7,686.56 to Fisher Scientific Company L.L.C., a major supplier of scientific products and equipment. The contract is for the delivery of 4,566,527,228 units of a "Vaginal Positive Control 6x.9ML/EA" product. This order does not utilize any set-aside designations. The contract has an ultimate completion date of December 2, 2024 and was awarded on November 22, 2024. Fisher...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,376.30 for vaginal negative control samples (6 x 0.9 mL per unit) on August 11, 2025, with an ultimate completion date of August 18, 2025. The contract employs a fixed-price pricing structure with economic price adjustment provisions and will be performed in Pittsburgh, Pennsylvania. This delivery order is issued under a larger contract vehicle and represents a pediatric purchase without set-aside designation,...
- This is a $2,199.58 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Fisher Scientific Company L.L.C. for the procurement of 4,564,072,591 units of "Vaginal Positive Control 6X.9ML/EA". The contract has an ultimate completion date of April 1, 2024. Fisher Scientific, a large for-profit limited liability company, is a major supplier of scientific products, equipment, and services to federal agencies such as the Department of Veterans Affairs, National...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D625F3EJWDelivery Order
Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $3,394.40 by the Department of Defense's Medical Supply Chain for the provision of vaginal positive control solutions (6 x 0.9 mL per unit). The contract, awarded on September 11, 2025, carries a fixed-price structure with economic price adjustment provisions and is scheduled for ultimate completion by September 18, 2025. Performance will take place in Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating it falls under a larger parent contracting vehicle, likely related to Fisher Scientific's established position as a critical supplier of laboratory and medical equipment to defense and civilian federal agencies. As a major supplier of scientific products and medical equipment registered in SAM.gov since 2001, Fisher Scientific demonstrates extensive federal contracting experience across multiple agencies including the Department of Veterans Affairs, National Institutes of Health, and Department of Defense. The award was made through open competition with no set-aside designation, consistent with Fisher Scientific's competitive procurement history. The vaginal positive control solutions being procured are essential quality assurance reagents used in laboratory testing protocols to verify the accuracy and reliability of diagnostic procedures and analytical instruments.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/11/25 |